• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症患者符号数字模态测验表现的轨迹。

Trajectories of Symbol Digit Modalities Test performance in individuals with multiple sclerosis.

机构信息

Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Boston, MA, USA/Department of Neurology, Harvard Medical School, Boston, MA, USA/Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA.

Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Boston, MA, USA/Department of Neurology, Harvard Medical School, Boston, MA, USA.

出版信息

Mult Scler. 2021 Apr;27(4):593-602. doi: 10.1177/1352458520913439. Epub 2020 Mar 31.

DOI:10.1177/1352458520913439
PMID:32228283
Abstract

BACKGROUND

Although cognitive problems have been identified in people with multiple sclerosis (PwMS), few studies have investigated the long-term change in cognitive functioning.

OBJECTIVE

To identify trajectories of change in cognitive functioning for PwMS.

METHODS

Participants enrolled in the quality-of-life subgroup from the Comprehensive Longitudinal Investigation of Multiple Sclerosis at Brigham and Women's Hospital (CLIMB) were eligible for our analysis. In 2006, participants in this group began to complete the Symbol Digit Modalities Test (SDMT) annually. Latent trajectory models were used to identify groups of participants with similar longitudinal change in SDMT scores. Linear and quadratic trajectory models were fit, and the models were compared. Latent trajectory models were also fit adjusting for baseline age and disease duration as well as using normalized SDMT scores. The groups identified across the approaches were compared.

RESULTS

We found that classes with higher-than-average baseline values improved, classes with average baseline values remained relatively constant, and classes with lower baseline values experienced cognitive worsening. Similar results were observed in the alternative latent trajectory models accounting for other variables.

CONCLUSION

Our models show that subjects with higher SDMT scores at baseline showed improvement, while subjects with lower SDMT scores at baseline showed worsening. Baseline age and disease duration were also associated with SDMT performance.

摘要

背景

尽管多发性硬化症(MS)患者存在认知问题,但很少有研究调查认知功能的长期变化。

目的

确定多发性硬化症患者认知功能变化的轨迹。

方法

有资格参加我们分析的是来自布里格姆妇女医院(Brigham and Women's Hospital)全面纵向多发性硬化症研究(Comprehensive Longitudinal Investigation of Multiple Sclerosis at Brigham and Women's Hospital,CLIMB)质量生活分组的参与者。2006 年,该组的参与者开始每年完成符号数字模态测试(SDMT)。使用潜在轨迹模型来识别 SDMT 评分具有相似纵向变化的参与者群体。拟合线性和二次轨迹模型,并比较模型。还通过调整基线年龄和疾病持续时间以及使用标准化 SDMT 分数来拟合潜在轨迹模型。比较了通过各种方法确定的组。

结果

我们发现基线值较高的类别的认知能力提高了,基线值中等的类别相对保持不变,而基线值较低的类别认知能力恶化了。在考虑其他变量的替代潜在轨迹模型中也观察到了类似的结果。

结论

我们的模型表明,基线 SDMT 得分较高的受试者表现出改善,而基线 SDMT 得分较低的受试者则表现出恶化。基线年龄和疾病持续时间也与 SDMT 表现相关。

相似文献

1
Trajectories of Symbol Digit Modalities Test performance in individuals with multiple sclerosis.多发性硬化症患者符号数字模态测验表现的轨迹。
Mult Scler. 2021 Apr;27(4):593-602. doi: 10.1177/1352458520913439. Epub 2020 Mar 31.
2
The Symbol Digit Modalities Test (SDMT) is sensitive but non-specific in MS: Lexical access speed, memory, and information processing speed independently contribute to SDMT performance.符号数字模式测试(SDMT)在多发性硬化症中具有敏感性但缺乏特异性:词汇访问速度、记忆和信息处理速度均独立影响 SDMT 的表现。
Mult Scler Relat Disord. 2021 Jun;51:102950. doi: 10.1016/j.msard.2021.102950. Epub 2021 Apr 11.
3
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.符号数字模态测验作为多发性硬化症认知障碍的哨兵测试。
Eur J Neurol. 2014 Sep;21(9):1219-25, e71-2. doi: 10.1111/ene.12463. Epub 2014 May 22.
4
A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test.多发性硬化症的快速电子认知评估工具:认知反应的验证,符号数字模态测试的电子版本。
J Med Internet Res. 2020 Sep 23;22(9):e18234. doi: 10.2196/18234.
5
Measuring cognitive function by the SDMT across functional domains: Useful but not sufficient.通过符号数字模式测验跨功能领域测量认知功能:有用但不充分。
Mult Scler Relat Disord. 2022 Apr;60:103704. doi: 10.1016/j.msard.2022.103704. Epub 2022 Feb 20.
6
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.复发缓解型多发性硬化症中符号数字模式测验(SDMT)和听觉序列加法测验(PASAT)的一年随访研究:比较纵向敏感性评估
BMC Neurol. 2015 Mar 22;15:40. doi: 10.1186/s12883-015-0296-2.
7
The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).符号数字模式测验是小儿多发性硬化症(MS)一种有效的认知筛查工具。
J Neurol Sci. 2014 Jun 15;341(1-2):79-84. doi: 10.1016/j.jns.2014.04.006. Epub 2014 Apr 13.
8
Symbol digit modalities test predicts decline of off-road driving ability in Japanese patients with multiple sclerosis.符号数字模态测试预测日本多发性硬化症患者越野驾驶能力下降。
Mult Scler Relat Disord. 2022 Dec;68:104150. doi: 10.1016/j.msard.2022.104150. Epub 2022 Aug 27.
9
Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.简要国际认知评估多发性硬化症(BICAMS):丹麦在多发性硬化症早期阶段的敏感性验证研究。
Mult Scler Relat Disord. 2020 Jan;37:101458. doi: 10.1016/j.msard.2019.101458. Epub 2019 Oct 18.
10
Does multilingualism act as a protective factor (cognitive reserve) against cognitive impairment in multiple sclerosis?: A retrospective cohort study.多语能力是否对多发性硬化症认知障碍起到保护作用(认知储备)?:一项回顾性队列研究。
Mult Scler Relat Disord. 2023 Dec;80:105060. doi: 10.1016/j.msard.2023.105060. Epub 2023 Oct 14.

引用本文的文献

1
Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis.血清神经胶质纤维酸性蛋白可预测多发性硬化症的疾病进展。
Ann Clin Transl Neurol. 2024 Oct;11(10):2719-2730. doi: 10.1002/acn3.52187. Epub 2024 Sep 5.
2
Effects of Physical Therapy and Dalfampridine on Function and Quality of Life in Nonambulatory Individuals With Multiple Sclerosis: A Randomized Controlled Trial.物理治疗和达氟吡啶对非行走型多发性硬化症患者功能及生活质量的影响:一项随机对照试验
Int J MS Care. 2024 May-Jun;26(3):98-103. doi: 10.7224/1537-2073.2023-063. Epub 2024 May 16.
3
Usability and acceptability of a cognitive training intervention (SMART) for people with multiple sclerosis (MS): A prefeasibility formative evaluation.
针对多发性硬化症(MS)患者的认知训练干预(SMART)的可用性和可接受性:一项预可行性形成性评估。
NIHR Open Res. 2022 May 23;2:39. doi: 10.3310/nihropenres.13274.1. eCollection 2022.
4
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.首发多发性硬化症疾病调节治疗后 11 年内认知处理速度和身体残疾的轨迹。
J Neurol Neurosurg Psychiatry. 2024 Jan 11;95(2):134-141. doi: 10.1136/jnnp-2023-331784.
5
Instruments measuring change in cognitive function in multiple sclerosis: A systematic review.用于多发性硬化症认知功能改变的测量仪器:系统评价。
Brain Behav. 2023 Jun;13(6):e3009. doi: 10.1002/brb3.3009. Epub 2023 Apr 16.
6
Objectively assessed physiological, physical, and cognitive function along with patient-reported outcomes during the first 2 years of Alemtuzumab treatment in multiple sclerosis: a prospective observational study.在多发性硬化症的 Alemtuzumab 治疗的头 2 年中,客观评估生理、身体和认知功能以及患者报告的结果:一项前瞻性观察研究。
J Neurol. 2022 Sep;269(9):4895-4908. doi: 10.1007/s00415-022-11134-7. Epub 2022 Apr 28.
7
Cognitive trajectories in multiple sclerosis: a long-term follow-up study.多发性硬化症中的认知轨迹:一项长期随访研究。
Neurol Sci. 2022 Feb;43(2):1215-1222. doi: 10.1007/s10072-021-05356-2. Epub 2021 Jun 8.
8
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.多发性硬化症的认知障碍:临床管理、MRI 和治疗途径。
Lancet Neurol. 2020 Oct;19(10):860-871. doi: 10.1016/S1474-4422(20)30277-5. Epub 2020 Sep 16.